Coherus Oncology, Inc. (NASDAQ:CHRS) Sees Significant Decline in Short Interest
MarketBeat
Coherus Oncology, Inc. (NASDAQ:CHRS - Get Free Report) was the recipient of a large decrease in short interest in the month of October. As of October 15th, there was short interest totaling 12,452,177 shares, a decrease of 46.6% from the September 30th total of 23,337,539 shares. Approximately 8.7% of the company's stock are short sold. Based on an average daily trading volume, of 1,579,236 shares, the days-to-cover ratio is presently 7.9 days.
NASDAQ:CHRS